Molekulargenetisches Labor
Zentrum für Nephrologie und Stoffwechsel
Moldiag Erkrankungen Gene Support Kontakt

Fibrodysplasia ossificans progressiva

Die Fibrodysplasia ossificans progressiva ist eine autosomal dominante Erkrankung, die durch aktivierende Mutationen des Aktivinrezeptors 1 hervorgerufen wird und durch extraskelettale vornehmlich endochondrale Ossifikationen gekennzeichnet ist. Die Patienten sind zunehmend durch Knochendeformationen und durch solche Verknöcherungen in ihrer Beweglichkeit eingeschränkt.

Epidemiologie

Die Prävalenz der Erkrankung wird mit 1:1-2.000.000 angegeben. Die meisten Fälle sind Neumutationen, da aufgrund der massiven Skelettveränderungen die Reproduktionskapazität erheblich eingeschränkt ist.[Error: Macro 'ref' doesn't exist]

Symptome

Extraossäre Ossification
Bei der Fibrodysplasia ossificans progressiva befinden sich die Ossifikationen vornehmlich in Sehnen, Bändern, Skelettmuskeln und Faszien. Vor dem Erscheinen des Knochengewebes zeigen sich schmerzhafte inflammatorische Knoten (“flare-ups”).

Gliederung

Erbliche Erkrankungen mit heterotroper Knochenbildung
Familiäre Tumorcalcinose
Fibrodysplasia ossificans progressiva
ACVR1
Progressive knöcherne Heteroplasie

Referenzen:

1.

Tünte W et al. (1967) [On the genetics of myositis ossificans progressiva].

external link
2.

Rogers JG et al. (1979) Fibrodysplasia ossificans progressiva. A survey of forty-two cases.

external link
3.

Maxwell WA et al. (1977) Histochemical and ultrastructural studies in fibrodysplasia ossificans progressiva (myositis ossificans progressiva).

external link
4.

Daltroff G et al. (1992) [Fibromatosis and fibrodysplasia ossificans progressiva. An avoidable diagnostic error].

external link
5.

de la Peña LS et al. (2005) Fibrodysplasia ossificans progressiva (FOP), a disorder of ectopic osteogenesis, misregulates cell surface expression and trafficking of BMPRIA.

external link
6.

Kitterman JA et al. (2005) Iatrogenic harm caused by diagnostic errors in fibrodysplasia ossificans progressiva.

external link
7.

Seemann P et al. (2008) The tale of FOP, NOGGIN and myristoylation: no data, no proof!

external link
8.

Kaplan FS et al. (2008) Response to "Mutations of the NOGGIN and of the activin A type I receptor genes in fibrodysplasia ossificans progressiva (FOP)" by Lucotte et al.

external link
9.

Shimono K et al. (2011) Potent inhibition of heterotopic ossification by nuclear retinoic acid receptor-γ agonists.

external link
10.

Rogers JG et al. (1979) Paternal age effect in fibrodysplasia ossificans progressiva.

external link
11.

Lin GT et al. (2006) De novo 617G-A nucleotide mutation in the ACVR1 gene in a Taiwanese patient with fibrodysplasia ossificans progressiva.

external link
12.

Connor JM et al. (1982) Genetic aspects of fibrodysplasia ossificans progressiva.

external link
13.

Schroeder HW et al. (1980) The hand and foot malformations in fibrodysplasia ossificans progressiva.

external link
14.

Kaplan FS et al. (1993) The histopathology of fibrodysplasia ossificans progressiva. An endochondral process.

external link
15.

Kaplan FS et al. (1993) Genetic transmission of fibrodysplasia ossificans progressiva. Report of a family.

external link
16.

Connor JM et al. (1993) A three generation family with fibrodysplasia ossificans progressiva.

external link
17.

Cohen RB et al. (1993) The natural history of heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. A study of forty-four patients.

external link
18.

Janoff HB et al. (1996) Fibrodysplasia ossificans progressiva in two half-sisters: evidence for maternal mosaicism.

external link
19.

Beratis NG et al. (1976) Alkaline phosphatase activity in cultured skin fibroblasts from fibrodysplasia ossificans progressiva.

external link
20.

Feldman G et al. (2000) Fibrodysplasia ossificans progressiva, a heritable disorder of severe heterotopic ossification, maps to human chromosome 4q27-31.

external link
21.

Shore EM et al. (2006) A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva.

external link
22.

Nakajima M et al. (2007) The ACVR1 617G>A mutation is also recurrent in three Japanese patients with fibrodysplasia ossificans progressiva.

external link
23.

Furuya H et al. (2008) A unique case of fibrodysplasia ossificans progressiva with an ACVR1 mutation, G356D, other than the common mutation (R206H).

external link
24.

Bocciardi R et al. (2009) Mutational analysis of the ACVR1 gene in Italian patients affected with fibrodysplasia ossificans progressiva: confirmations and advancements.

external link
25.

Kaplan FS et al. (2009) Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1.

external link
26.

Petrie KA et al. (2009) Novel mutations in ACVR1 result in atypical features in two fibrodysplasia ossificans progressiva patients.

external link
27.

Barnett CP et al. (2011) Late-onset variant fibrodysplasia ossificans progressiva leading to misdiagnosis of ankylosing spondylitis.

external link
28.

Smith R et al. (1976) Myositis ossificans progressiva. Clinical features of eight patients and their response to treatment.

external link
29.

Kan L et al. (2004) Transgenic mice overexpressing BMP4 develop a fibrodysplasia ossificans progressiva (FOP)-like phenotype.

external link
30.

Shafritz AB et al. (1996) Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva.

external link
31.

Lucotte G et al. (1999) A de novo heterozygous deletion of 42 base-pairs in the noggin gene of a fibrodysplasia ossificans progressiva patient.

external link
32.

Xu MQ et al. (2000) Linkage exclusion and mutational analysis of the noggin gene in patients with fibrodysplasia ossificans progressiva (FOP).

external link
33.

Sémonin O et al. (2001) Identification of three novel mutations of the noggin gene in patients with fibrodysplasia ossificans progressiva.

external link
34.

Xu MQ et al. (2002) Reported noggin mutations are PCR errors.

external link
35.

None (2002) Significant difference of opinion regarding the role of noggin in fibrodysplasia ossificans progressiva.

external link
36.

Fontaine K et al. (2005) A new mutation of the noggin gene in a French Fibrodysplasia ossificans progressiva (FOP) family.

external link
37.

Lucotte G et al. (2007) Mutations of the noggin and of the activin A type I receptor genes in fibrodysplasia ossificans progressiva (FOP).

external link
38.

Lucotte G et al. (2000) Localization of the gene for fibrodysplasia ossificans progressiva (FOP) to chromosome 17q21-22.

external link
39.

OMIM.ORG article

Omim 135100 external link
40.

Orphanet article

Orphanet ID 337 external link
41.

Wikipedia Artikel

Wikipedia DE (Fibrodysplasia_ossificans_progressiva) external link
Update: 14. August 2020
Copyright © 2005-2020 Zentrum für Nephrologie und Stoffwechsel, Dr. Mato Nagel
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Deutschland, Tel.: +49-3576-287922, Fax: +49-3576-287944
Seitenüberblick | Webmail | Haftungsausschluss | Datenschutz